Literature DB >> 8700897

Enhanced and accelerated lymphoproliferation in Fas-null mice.

M Adachi1, S Suematsu, T Suda, D Watanabe, H Fukuyama, J Ogasawara, T Tanaka, N Yoshida, S Nagata.   

Abstract

Fas is a 45-kDa membrane protein that transduces an apoptotic signal. The mouse lymphoproliferation (lpr) mutation is a leaky mutation of Fas. In this study, we examined lymphocyte development in Fas-null mice generated by gene targeting. The Fas-/- mice progressively accumulated abnormal T cells (Thy1+, B220+, CD4-, and CD8-) and developed lymphadenopathy and splenomegaly, which were much more accelerated and pronounced than those in lpr mice. In addition, the Fas-null mice showed lymphocytosis, accompanied by lymphocytic infiltration in the lungs and liver. The number of apparently normal B cells also increased, and large amounts of immunoglobulins, including anti-DNA antibodies, were produced. Thymic clonal deletion, assessed by deletion of T cells reactive to mouse endogenous superantigens, was apparently normal in the Fas-/- mice, whereas the peripheral clonal deletion of mature T cells against a bacterial superantigen was impaired. These results suggested that Fas plays a decisive role in peripheral clonal deletion but not in negative selection in the thymus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700897      PMCID: PMC39922          DOI: 10.1073/pnas.93.5.2131

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

Authors:  R Watanabe-Fukunaga; C I Brannan; N Itoh; S Yonehara; N G Copeland; N A Jenkins; S Nagata
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

Review 2.  Early and late B-cell development in the mouse.

Authors:  K Rajewsky
Journal:  Curr Opin Immunol       Date:  1992-04       Impact factor: 7.486

3.  Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.

Authors:  H R MacDonald; S Baschieri; R K Lees
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

4.  Peripheral selection of the T cell repertoire.

Authors:  B Rocha; H von Boehmer
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Peripheral deletion of self-reactive B cells.

Authors:  D M Russell; Z Dembić; G Morahan; J F Miller; K Bürki; D Nemazee
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

6.  Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells.

Authors:  D Watanabe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1995-12       Impact factor: 4.823

7.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

Authors:  N Itoh; S Yonehara; A Ishii; M Yonehara; S Mizushima; M Sameshima; A Hase; Y Seto; S Nagata
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

8.  Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice.

Authors:  C L Sidman; J D Marshall; H Von Boehmer
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

9.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

Review 10.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

View more
  49 in total

Review 1.  TRAIL, Bim, and thymic-negative selection.

Authors:  Shi-Jun Zheng; Youhai H Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.

Authors:  Ichiko Kinjyo; Scott M Gordon; Andrew M Intlekofer; Kennichi Dowdell; Erin C Mooney; Roberto Caricchio; Stephan A Grupp; David T Teachey; V Koneti Rao; Tullia Lindsten; Steven L Reiner
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

3.  Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis.

Authors:  Alfredo Prieto; David Díaz; Hugo Barcenilla; Carmen Castrillo; Jorge Monserrat; Antonio García Merino; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

Review 4.  Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.

Authors:  Sabine Adam-Klages; Dieter Adam; Ottmar Janssen; Dieter Kabelitz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Apoptosis in B-chronic lymphocytic leukaemia.

Authors:  L M Osorio; M Aguilar-Santelises
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

6.  Soluble FasR ligand-binding domain: high-yield production of active fusion and non-fusion recombinant proteins using the baculovirus/insect cell system.

Authors:  J Mahiou; J P Abastado; L Cabanie; F Godeau
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 7.  Immunopathology of apoptosis--introduction and overview.

Authors:  D L Vaux
Journal:  Springer Semin Immunopathol       Date:  1998

Review 8.  Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

Authors:  J P de Villartay; F Rieux-Laucat; A Fischer; F Le Deist
Journal:  Springer Semin Immunopathol       Date:  1998

9.  A role for perforin in downregulating T-cell responses during chronic viral infection.

Authors:  M Matloubian; M Suresh; A Glass; M Galvan; K Chow; J K Whitmire; C M Walsh; W R Clark; R Ahmed
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Exposure to inorganic mercury in vivo attenuates extrinsic apoptotic signaling in Staphylococcal aureus enterotoxin B stimulated T-cells.

Authors:  Michael D Laiosa; Kevin G Eckles; Margaret Langdon; Allen J Rosenspire; Michael J McCabe
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-19       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.